News | May 07, 2026
CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
The site’s GMP Certification has been successfully renewed
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
